These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33444845)

  • 1. Strategies to prolong the residence time of drug delivery systems on ocular surface.
    Grassiri B; Zambito Y; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on topical ophthalmic drug delivery system: Reference to viscosity enhancer.
    Pawar PK; Rathod RD; Jagadale SR
    Polim Med; 2024; 54(1):71-84. PubMed ID: 38533624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gelling and mucoadhesive polymers: why do they need each other?
    Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
    Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
    Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical ocular drug delivery systems: Innovations for an unmet need.
    Yang Y; Lockwood A
    Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.
    Vigani B; Rossi S; Sandri G; Bonferoni MC; Caramella CM; Ferrari F
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
    Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
    Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Advances in Mucoadhesive Ocular Drug Delivery System.
    Billowria K; Sandhu NK; Singh B
    Curr Drug Deliv; 2023; 20(8):1127-1140. PubMed ID: 36221885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Updates on Nanocarriers for Drug Delivery in Posterior Segment Diseases with Emphasis on Diabetic Retinopathy.
    Parashar R; Vyas A; Sah AK; Hemnani N; Thangaraju P; Suresh PK
    Curr Diabetes Rev; 2024; 20(6):e171023222282. PubMed ID: 37855359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
    Sah AK; Suresh PK
    Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
    Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
    J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.